Ramón Soto‐Otero - Concepedia

Author

Ramón Soto‐Otero

Universidade de Santiago de Compostela ORCID

Also Known As

R Soto-Otero, R. Soto-Otero, R. Soto‐Otero, Ramon Soto-Otero, Ramon Soto-otero, Ramon Soto‐Otero, RamÓN Soto-otero, Ramón Soto-Otero, Ramón Soto‐Otero

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

Universidade de Santiago de Compostela University of Bari Aldo Moro Biomedical Research Networking Center on Neurodegenerative Diseases University of Lausanne Peoples' Friendship University of Russia

About

Ramón Soto‐Otero is an author at Universidade de Santiago de Compostela specializing in medicine, pharmacology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	32	1.9K
2	Biochemistry	13	15	854
3	Social Sciences	11	11	567
4	Natural Sciences	9	9	608
5	Health Sciences	1	1	32

Ramón Soto‐Otero

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
Autoxidation and Neurotoxicity of 6‐Hydroxydopamine in the Presence of Some Antioxidants Ramón Soto‐Otero, Estefanı́a Méndez-Álvarez, Á. Hermida Ameijeiras, Journal of Neurochemistry	2000	309
Effects of (−)-nicotine and (−)-cotinine on 6-hydroxydopamine-induced oxidative stress and neurotoxicity: relevance for Parkinson’s disease Ramón Soto‐Otero, Estefanı́a Méndez-Álvarez, Á. Hermida Ameijeiras, Biochemical Pharmacology 6-Hydroxydopamine-induced Oxidative StressMedicineNicotineParkinson ’Neuropharmacology	2002	145
Antioxidant properties of dimethyl sulfoxide and its viability as a solvent in the evaluation of neuroprotective antioxidants Carolina Sanmartín‐Suárez, Ramón Soto‐Otero, Inés Sánchez‐Sellero, Journal of Pharmacological and Toxicological Methods Neuroprotective AntioxidantsDimethyl SulfoxideBiochemistryMedicineLipid Peroxidation	2010	136
A QSAR Model for in Silico Screening of MAO-A Inhibitors. Prediction, Synthesis, and Biological Assay of Novel Coumarins Lourdes Santana, Eugenio Uriarte, Humberto González‐Díaz, Journal of Medicinal Chemistry Drug TargetOrganic ChemistryPharmacotherapyChemistrySilico Screening	2005	135
Mitochondrial angiotensin receptors in dopaminergic neurons. Role in cell protection and aging-related vulnerability to neurodegeneration Rita Valenzuela, Maria A. Costa-Besada, Javier Iglesias‐González, Cell Death and Disease	2016	111
Angiotensin type-1-receptor antagonists reduce 6-hydroxydopamine toxicity for dopaminergic neurons P. Rey, Ana Marı́a López-Real, Sofía Sánchez‐Iglesias, Neurobiology of Aging NeurophysiologyDopaminergic NeuronsMedicineNeuropeptide ReceptorNeuropharmacology	2006	108
Structural Insights into Monoamine Oxidase Inhibitory Potency and Selectivity of 7-Substituted Coumarins from Ligand- and Target-Based Approaches Marco Catto, Orazio Nicolotti, Francesco Leonetti, Journal of Medicinal Chemistry	2006	107
Angiotensin‐converting enzyme inhibition reduces oxidative stress and protects dopaminergic neurons in a 6‐hydroxydopamine rat model of Parkinsonism Ana Marı́a López-Real, P. Rey, Ramón Soto‐Otero, Journal of Neuroscience Research	2005	106
Discovery of a Novel Class of Potent Coumarin Monoamine Oxidase B Inhibitors: Development and Biopharmacological Profiling of 7-[(3-Chlorobenzyl)oxy]-4-[(methylamino)methyl]-2<i>H</i>-chromen-2-one Methanesulfonate (NW-1772) as a Highly Potent, Selective, Reversible, and Orally Active Monoamine Oxidase B Inhibitor Leonardo Pisani, Giovanni Muncipinto, Teresa Fabiola Miscioscia, Journal of Medicinal Chemistry	2009	105
Structure-Based Design and Optimization of Multitarget-Directed 2<i>H</i>-Chromen-2-one Derivatives as Potent Inhibitors of Monoamine Oxidase B and Cholinesterases Roberta Farina, Leonardo Pisani, Marco Catto, Journal of Medicinal Chemistry PharmacotherapyChemical BiologyPharmaceutical ChemistryMedicinal ChemistryStructure-based Design	2015	98

Page 1